Advertisement

Topics

ERSPC (European Randomized Study of Screening for Prostate Cancer) Company Profile

18:21 EST 15th December 2018 | BioPortfolio


News Articles [6777 Associated News Articles listed on BioPortfolio]

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer

What should doctors say to men asking for a PSA test?

A BMJ Rapid Recommendation in this issue1 reviews the evidence2 behind prostate cancer screening, including the latest large trial of prostate cancer screening with the prostate-specific antigen...

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

What you need to knowPSA testing has increased the number of men diagnosed with and treated for prostate cancer, but many of these men would never have experienced any symptoms or death from prostate....

African American Men and Prostate Cancer: Be Your Own Advocate and Understand Screening

This article addresses prostate cancer screening and the research around its potential benefits and harms.

Prostate Cancer Screening: Harms Beat Benefits

Dr Charles Vega comments on two studies, each looking at a different issue related to prostate cancer screening. Medscape Internal Medicine

Does Prostate Cancer Screening Decrease Mortality?

Dr Gerald Chodak discusses recent findings from a retrospective analysis on the magnitude of benefit with prostate cancer screening. Medscape Urology

More doctors say men should think twice about prostate cancer screening

(Reuters Health) - Most men shouldn't get routine prostate cancer screening because the potential benefits are small and there are clear harms, an international panel of experts concludes.

Have Relaxed PSA Recs Resulted in Unchecked Prostate Cancer?

Are patients being diagnosed with more advanced prostate cancer now that PSA screening recommendations have changed? Dr Chodak reviews a study seeking to answer this question. Medscape Urology

Drugs and Medications [843 Associated Drugs and Medications listed on BioPortfolio]

Avodart [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Preferred Pharmaceuticals, Inc]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Fareston [GTx, Inc.]

These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®.FARESTON® (toremifene citrate) 60 mg Tablets oral ...

Jalyn [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN.JALYN (dutasteride and tamsulosin hydrochloride) CapsulesInit...

PubMed Articles [14857 Associated PubMed Articles listed on BioPortfolio]

The Influence of decision aids on prostate cancer screening preferences: A randomized survey study.

Shared decision making is recommended regarding prostate cancer screening. Decision aids may facilitate this process; however, the impact of decision aids on screening preferences is poorly understood...

Predictors of participation in risk-based prostate cancer screening.

Implementation of risk-based prostate cancer screening has been proposed as a means to reduce the harms of PSA screening. Little is known, however, about the factors influencing men's decision to atte...

Overdiagnosis in Colorectal Cancer Screening - Time to Acknowledge A Blind Spot.

Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more bro...

New Evidence for the Benefit of PSA Screening: Data From 400,887 Kaiser Permanente Patients.

To investigate whether prostate cancer screening with PSA is beneficial in reducing prostate cancer mortality, and to determine optimal screening intervals and age groups to be screened.

Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement.

Clinical Trials [18016 Associated Clinical Trials listed on BioPortfolio]

Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening

The incidence of prostate cancer has been rising steadily both globally and in Malaysia. Besides an ageing population, another reason cited to explain the increase, is the corresponding in...

A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)

A population-based randomised trial of prostate cancer screening will be carried out. A total of approximately 67,000 men aged 50-63 in Helsinki and Tampere are randomised to intervention ...

Facilitating Shared Decisionmaking About Prostate Cancer Screening

Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.

Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients

RATIONALE: Screening for cancer may enable doctors to discover and treat the disease earlier. PURPOSE: Randomized trial to determine if screening methods used to diagnose cancer of the ...

Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening

The purpose of this study is to evaluate a new counseling tool for patients deciding whether or not to undergo prostate cancer screening. This screening decision aid is a computer program ...

Companies [3040 Associated Companies listed on BioPortfolio]

ERSPC (European Randomized Study of Screening for Prostate Cancer)

European Randomized Study of Screening for Prostate Cancer (ERSPC)

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

Stratify Genomics, Inc.

Currently, there are 35,000 men annually who are unaware of a curable form of clinically significant prostate cancer. Relying solely on family history, 80% of prostate cancer case...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

More Information about "ERSPC (European Randomized Study of Screening for Prostate Cancer)" on BioPortfolio

We have published hundreds of ERSPC (European Randomized Study of Screening for Prostate Cancer) news stories on BioPortfolio along with dozens of ERSPC (European Randomized Study of Screening for Prostate Cancer) Clinical Trials and PubMed Articles about ERSPC (European Randomized Study of Screening for Prostate Cancer) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERSPC (European Randomized Study of Screening for Prostate Cancer) Companies in our database. You can also find out about relevant ERSPC (European Randomized Study of Screening for Prostate Cancer) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record